Oil Based Depot & Other Long-Acting Intramuscular Antipsychotic Injections – A Report From Janssen UK
On February 2014, Janssen UK commissioned this 4th edition report on long-acting intramuscular antipsychotic injections. The report includes information on oil-based depot injections, other long-acting antipsychotic intramuscular injections, advantages and disadvantages of long-acting antipsychotic intramuscular injections, and safer care through risk management. The guidance is intended as a clinical companion for all mental health care professionals and includes specific Standard Operating Procedures (SOPs) for administering intramuscular injections in each of the licensed depot and long acting injection sites for patients with severe mental illness such schizophrenia.
The fourth edition was edited by Celia Feetam, Clinical Psychiatric . . .
